Ayala Pharmaceuticals, Inc. (20) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company, as amended
(Filed With SEC on May 4, 2020)
-
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company
(Filed With SEC on March 6, 2020)
-
Evaluation, Option and License Agreement, dated December 19, 2018, between the Registrant and Novartis International Pharmaceutical Limited
(Filed With SEC on March 6, 2020)